CompanyDrug

Clover Biopharma’s SCB-2019 Vaccine Shows Strong Immune Response to Omicron BA.5

CompanyDrug

Staidson and J&J’s Teclistamab Gain Breakthrough Designation for Hemophilia and Myeloma

CompanyDeals

Fosun Pharma to Invest RMB 1B in Chengdu Vaccine Base

CompanyDrug

InnoCare Pharma and CStone Pharmaceuticals’ Drugs Receive Prioritized CDE Review

CompanyDeals

Luca Healthcare Raises Pre-Series A Funding for Digital Biomarker R&D

CompanyDrug

Biocytogen and Tracon Pharmaceuticals Gain FDA IND Approval for Sarcoma Trial

CompanyDrug

Hengrui Medicine’s Dalpiciclib Hits Superiority Criteria in Phase III Study

Company

Ascentage Pharma’s H1 2022 Revenue Surges 636.9% on Olverembatinib Sales

CompanyPolicy / Regulatory

China-U.S. Listing Agreement Clears Path for Chinese Firms to Stay Listed in the U.S.

Policy / Regulatory

Shandong Releases Off-Label Drug Use Consensus, Expanding Clinical Guidance

CompanyDrug

ImmuneOnco’s IMM40H Receives NMPA Clinical Trial Approval for CD70 Antibody

CompanyDeals

InnoCare Pharma Files for STAR Market IPO to Raise RMB 4B for Drug R&D